Indication

Emergency treatment of severe capecitabine toxicity

Emergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration. Read more about Emergency treatment of severe capecitabine toxicity

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Emergency treatment of severe capecitabine toxicity therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Emergency treatment of severe capecitabine toxicity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Emergency treatment of severe capecitabine toxicity.

Emergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration.

Capecitabine is an orally administered prodrug of 5-fluorouracil, and profound toxicity typically arises from accidental overdose or impaired clearance due to dihydropyrimidine dehydrogenase (DPD) enzyme deficiency.

This clinical state affects adult and pediatric cancer patients, manifesting as early-onset, rapidly progressive dysfunction across multiple organ systems, most notably cardiovascular collapse, central nervous system impairment, refractory gastrointestinal injury such as severe mucositis or diarrhea, and profound neutropenia.

Immediate intervention aims to arrest cellular injury and prevent fatal multiorgan failure by mitigating the toxic incorporation of fluorinated metabolites into cellular RNA and DNA.

Personalize your experience

Follow Emergency treatment of severe capecitabine toxicity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it